Goldstraw, P., Chansky, K., Crowley, J., Rami-Porta, R., Asamura, H., Eberhardt, W.E., Nicholson, A.G., Groome, P., Mitchell, A. and Bolejack, V. (2016) The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. Journal of Thoracic Oncology, 11, 39-51.
https://doi.org/10.1016/j.jtho.2015.09.009

has been cited by the following article:

• TITLE: Impact of Preoperative Serum Tumor Markers in Patients with Lung Squamous Cell Carcinoma

  AUTHORS: Masaki Tomita, Shoei Kuroki, Tomoka Hamahiro, Ryo Maeda, Takanori Ayabe

  KEYWORDS: Lung Squamous Cell Carcinoma, Cytokeratin-19 Fragment, Squamous Cell Carcinoma Antigen

  JOURNAL NAME: Advances in Lung Cancer, Vol.10 No.3, September 9, 2021

  ABSTRACT: Background: Several previous researchers have investigated the prognostic value of serum tumor markers, especially carcinoembryonic antigen (CEA). Only a limited number of studies reported the usefulness of serum tumor markers for lung squamous cell carcinoma (SQ). We aimed to examine the significance of serum tumor markers for lung SQ. Methods: Eighty-five lung SQ patients who underwent surgery and followed more than 5-year were included. The ratios of 5-year survivors to all patients in groups with several clinicopathologic factors, including tumor markers, were compared. We also compared the clinicopathologic factors between central type and peripheral type SQ. Results: The majority of patients were male gender and current/ former smokers. Age, pN status, cytokeratin-19 fragment (CYFRA 21-1), squamous cell carcinoma antigen (SCC), and comorbid interstitial pneumonia (IP) were associated with the ratio of 5-year survivors significantly. When patients were compared based on tumor location, high p-stage and CYFRA 21-1 were related to central type SQ. Conclusion: Both SCC and CYFRA 21-1 appeared to be useful prognostic markers for patients with lung SQ. Furthermore, CYFRA 21-1 was related to central type SQ.